Risk factors for anxiety, depression, stress, and their comorbidities among nurses: a prospective cohort from 2020 to 2022.

Risk factors for anxiety, depression, stress, and their comorbidities among nurses: a prospective cohort from 2020 to 2022.

Publication date: Dec 18, 2024

Nurses are at the forefront of healthcare delivery during the COVID-19, placing them at an increased risk for mental health issues. This study aimed to identify the risk factors for anxiety, depression, stress, and their comorbidities among nurses during the 2020-2022 period. A prospective cohort of nurses in Zunyi City, China, was followed from 2020 to 2022. The Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and Perceived Stress Scale (PSS) were used to assess anxiety, depression, and stress, respectively. A self-reported questionnaire was utilized to collect data on demographic characteristics, lifestyle habits, socioeconomic status, work-related factors, and medical history. The Healthy Eating Index (HEI) was calculated to evaluate diet quality. Univariate and multivariate logistic regression analyses were conducted to examine the associations between risk factors and mental health outcomes. Among the 516 participating nurses, the incidence rates of new-onset anxiety, depression, and stress were 27. 1%, 33. 9%, and 39. 9%, respectively. Frontline experience with infected patients, night shift work, longer working hours, and higher body mass index were consistently associated with increased risks of anxiety, depression, and stress, whereas a higher healthy eating index score was linked to reduced odds of these mental health outcomes. Notably, higher BMI (≥ 28: OR = 1. 67, 95% CI: 1. 12-2. 16, p = 0. 011), night shifts (> 1/week: OR = 5. 12, 95% CI: 3. 64-5. 99, p  40/week: OR = 1. 99, 95% CI: 1. 66-2. 89, p 

Open Access PDF

Concepts Keywords
China Anxiety
Eating Cohort study
Nurses Comorbidities
Socioeconomic Depression
Nurses
Stress

Semantics

Type Source Name
disease MESH anxiety
disease MESH depression
disease MESH COVID-19
drug DRUGBANK Sodium lauryl sulfate
disease MESH lifestyle
disease IDO history
disease IDO quality
pathway REACTOME Reproduction
disease MESH comorbidity
drug DRUGBANK Trestolone
drug DRUGBANK Isoxaflutole
drug DRUGBANK Coenzyme M
disease MESH pneumonia
disease MESH critically ill
disease MESH psychological distress
disease MESH psychological well being
drug DRUGBANK Ademetionine
disease MESH cognitive impairment
disease IDO process
disease MESH marital status
disease MESH education level
disease MESH hypertension
drug DRUGBANK Cholesterol
drug DRUGBANK Aspartame

Original Article

(Visited 1 times, 1 visits today)